URGO resistant warts pen is a medical device indicated for the home treatment of stubborn warts on the hands and feet, in adults and children aged over 4
The URGO resistant warts pen is an effective, precise and convenient method for removing the most stubborn warts at home.
Read the instructions carefully before use. The URGO resistant warts pen contains a highly effective but corrosive gel. For external use on hands and feet only. If you are unsure whether your skin condition is a wart, consult a doctor before use.
Important: before treatment, protect the surrounding healthy skin by applying a thin layer of petroleum jelly around the wart. Do not apply petroleum jelly around the wart as this may reduce the effectiveness of the treatment.
1. To open the pen, turn the cap until the 2 red arrows align, then pull.
2. On first use, press the push button several times with 5 seconds between each press, until the blue-tinted gel appears in the transparent part of the applicator tip. One drop of gel (1 click) is sufficient for one application. If a single drop does not fully cover the wart, apply a second directly to the wart, without touching the healthy skin.
3. Hold the pen vertically with the applicator facing downwards to allow the gel to reach the tip.
4. Apply a single drop of gel carefully and precisely to the wart only. The blue tint makes it easy to see where the gel has been applied.
5. If the gel accidentally contacts healthy skin, rinse thoroughly with clean water and soap to prevent irritation or burns.
6. After application, leave the gel to dry for 10-15 minutes before putting on clothes or shoes.
7. Repeat twice a day for 4 days. For children with smaller warts, apply once a day for 4 days.
8. Wipe the applicator thoroughly with a tissue to remove excess gel. Close the pen with the cap and ensure the red arrows are not aligned.
9. During treatment, the wart will darken and the skin will form a crust. Depending on the size of the wart, it should disappear 1-2 weeks after the end of treatment, leaving smoother, slightly pink skin that will return to its natural colour in the following weeks.
10. Do not expose the treated area to the sun until the skin has regained its natural colour.
11. If the wart does not disappear completely, treatment may be repeated after a 4-day break. Treatment can be carried out up to a maximum of 4 times. If the wart has not disappeared after the fourth treatment, consult your doctor.
Number of applications:
Children from 4 years of age: 1 application per day for 4 days
Adults: 2 applications per day for 4 days
Warts appear in many forms, mainly on the feet and hands. Common or common warts are usually rough and hard and look like a "cauliflower". Plantar warts often have hard, thick edges with black dots in the centre. Unsightly and recurring, warts can be annoying or even painful.
TCA-Active™, Carbopol, Methyl Blue, Water
Do not use in the following cases:
- On any part of the body other than the hands or feet.
- On bleeding, irritated, inflamed skin, or skin showing signs of inflammation such as itching or swelling.
- On moles, hyperpigmentation, brown spots, freckles or skin lesions caused by molluscum contagiosum (water warts), seborrheic warts or flat warts.
- If you are unsure whether your skin condition is a common or plantar wart.
- If you are hypersensitive to any of the ingredients.
- In children under 4 years of age.
- In combination with another wart treatment. Wait until the wart has returned to its original appearance (no irritation or redness) before commencing the treatment.
Consult your doctorbefore use if:
– You are pregnant or breastfeeding;
– You have circulation disorders, skin conditions or diabetes
- The URGO resistant warts pen contains a corrosive acid. Apply to warts on the HANDS and FEET ONLY.
- If the gel comes into contact with healthy skin, rinse immediately with clean water and soap.
- For external use only.
- On first-time use, apply to a single wart before treating multiple warts.
- Do not expose the treated skin to sunlight until it is fully healed. This skin renewal process can take 4 to 6 weeks. Prolonged sun exposure may cause hypo or hyperpigmentation.
- Do not touch the treated skin - warts are contagious.
- Do not scratch or pull off the treated wart - allow it to fall off naturally.
- Do not bring the product near the mouth or eyes. After treating warts on the hands, wash your hands after 5 minutes to avoid contact with eyes or mucous membranes. If accidental contact with eyes or mucous membranes occurs, rinse thoroughly with clean water and consult your doctor.
- For hygiene reasons, use the pen for a single user. Do not reuse on other users. Discard the pen at the end of treatment.
Avoid contact with jewellery, clothing, fabrics, or furniture - the pen may damage them.
- After each use, gel residue may remain in the cap - handle the cap carefully when opening and closing.
- Keep the treated area clean to prevent infection.
Consult a doctor if:
– the wart has not disappeared after 4 treatment periods (4 weeks);
– you experience irritation, redness or pain;
– the wart is damaged, bleeding, red, or painful, or if the surrounding skin is red or painful.
The gel is slightly blue, which enables a more precise application to the wart.
After application, the treated area may appear slightly blue. This is harmless and disappears easily when rinsed. Take care not to touch the wart which may be contagious.
For warts with calluses, soak the area in hot water and exfoliate before treatment to avoid staining the calluses.
Our advice and tips
URGO resistant warts pen. This medical device is a regulated health product bearing the CE marking under the applicable regulations. Indication: treatment of hand and foot warts with TCA-Active TM. From 4 years of age. Consult your doctor if you are pregnant or breastfeeding, have diabetes, have blood circulation disorders, or have a skin condition. Seek advice from your doctor or pharmacist and read the package leaflet before use. Medical Brands Innovations B.V. Distributor: Laboratoires URGO Healthcare – 21300 CHENÔVE- RCS DIJON 798 251 559 – Share capital €56,280,458. MM/YYYY
